Vedanta Biosciences, Inc.
USPTO PatentsView assignee record - 15 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Vedanta ranks #19,321 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 8 technology areas.
- #19,321
- of 49,997 US assignees by volume
- Top 49%
- by Innovation Score (35.5/100)
- 15.5
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R19321 · US Corporation #19,321 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #19,321/49,997
- PHOTO-FINISH Valo Early Discovery
- CPC-NARROW A61K · 8 areas
- INNOV-THIN 35.5/100
- CLAIMS-RICH 15.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Valo Early Discovery, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Vedanta’s 35.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Vedanta
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Vedanta Biosciences · this assignee
Vedanta Biosciences · this assignee
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Vedanta's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Vedanta?
Each dot is one of Vedanta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vedanta’s own 15.5 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Vedanta's grants concentrate
Vedanta Biosciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 86.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Vedanta sits between Valo Early Discovery, Inc. and Vi-Jon, LLC.
Vedanta's three-year grant acceleration
Vedanta Biosciences, Inc. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Vedanta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Valo Early Discov…
Valo Early Discovery, Inc.
15 patents
- Valve Medical
Valve Medical Ltd.
15 patents
- Vascular Imaging
Vascular Imaging Corporation
15 patents
- Vaxxas Pty
Vaxxas Pty Limited
15 patents
- Venturemed Group
VentureMed Group, Inc.
15 patents
- Veritone Alpha
Veritone Alpha, Inc.
15 patents
- Verona Pharma
Verona Pharma PLC
15 patents
- Vi-jon
Vi-Jon, LLC
15 patents
- Vedanta Bioscienc… ◀
Vedanta Biosciences, Inc.
15 patents
What this shows Vedanta holds 15 patents at rank #19,322, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Vedanta
By rank, the assignees closest to #19,322 in granted patent volume.
- Valo Early Discovery, Inc. #19,318 · 15 patents
- Valve Medical Ltd. #19,319 · 15 patents
- Vascular Imaging Corporation #19,320 · 15 patents
- Vaxxas Pty Limited #19,321 · 15 patents
- VentureMed Group, Inc. #19,323 · 15 patents
- Veritone Alpha, Inc. #19,324 · 15 patents
- Verona Pharma PLC #19,325 · 15 patents
- Vi-Jon, LLC #19,326 · 15 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Vedanta's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Vedanta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 6.7% |
| 2018 | 3 | 20.0% |
| 2019 | 3 | 20.0% |
| 2020 | 1 | 6.7% |
| 2021 | 1 | 6.7% |
| 2022 | 1 | 6.7% |
| 2023 | 2 | 13.3% |
| 2024 | 2 | 13.3% |
| 2025partial year | 1 | 6.7% |
Which technologies does Vedanta Biosciences, Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Vedanta Biosciences, Inc.'s patent record in context - here's where to go next.
- Vedanta Biosciences, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 86.7% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #19,321 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Vedanta Biosciences, Inc. against Valo Early Discovery, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.